Tilray Brands, Inc. (TSX:TLRY)
13.18
-0.39 (-2.87%)
At close: Jan 16, 2026
Tilray Brands Employees
Tilray Brands had 2,842 employees as of May 31, 2025. The number of employees increased by 192 or 7.25% compared to the previous year.
Employees
2,842
Change (1Y)
192
Growth (1Y)
7.25%
Revenue / Employee
411.61K CAD
Profits / Employee
-1.04M CAD
Market Cap
1.53B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 2,842 | 192 | 7.25% |
| May 31, 2024 | 2,650 | 1,050 | 65.63% |
| May 31, 2023 | 1,600 | -200 | -11.11% |
| May 31, 2022 | 1,800 | -300 | -14.29% |
| May 31, 2021 | 2,100 | 900 | 75.00% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| WELL Health Technologies | 1,507 |
| Vireo Growth | 520 |
Tilray Brands News
- 1 day ago - 3 Canadian Marijuana Stocks For Investors In 2026 - MarijuanaStocks
- 3 days ago - What's Next for Tilray Brands After Posting Record Q2 Revenues? - Nasdaq
- 4 days ago - Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings? - Nasdaq
- 7 days ago - International Cannabis Expansion Gives Tilray Positive 2026 Outlook - Seeking Alpha
- 8 days ago - Tilray Valuation Attractive With Strong Growth Overseas, Analyst Says - Benzinga
- 8 days ago - Tilray Stock Couldn’t Sustain Its Trump Gains. How Cannabis Earnings Could Help. - Barron's
- 8 days ago - These Stocks Are Moving the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More - Barron's
- 8 days ago - Marijuana industry taking fight against Wall Street blockades straight to Trump - New York Post